Very Low Carbohydrate Diet as an Adjunctive Therapy for Youth Type 1 Diabetes

Type 1 Diabetes Clinical Trial

Official title:

Very Low Carbohydrate Diet as an Adjunctive Therapy for Youth Type 1 Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04082884
• Other study ID #: 2000026189
• Secondary ID: 2K12DK094714-06
• Status: Completed
• Phase: N/A
• Start date: June 25, 2020
• Est. completion date: February 20, 2022

Study information

• Verified date: February 2024
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This prospective, open-label pilot/feasibility study of 10 youth with T1D is to evaluate glycemic and metabolic changes taking place with a very low carbohydrate diet.

Description:

First, to evaluate the feasibility of following each type of VLCD (high protein or high fat), participants will follow a standard carbohydrate diet for 2 weeks, followed by a 1 week transition to a VLCD, and then follow the a high protein VLCD for 2 weeks followed by a high fat VLCD for 2 weeks. The study will consist of 4 in person or virtual visits which will take place over ~7 weeks. All participants will be initially studied for 2 weeks while ingesting a standard diet recommended by the American Diabetes Association, followed by a 1-week transition to a VLCD, and followed by 2 weeks on each type of VLCD (high protein, high fat). During the first (baseline) period fasting β-hydroxybutyrate levels will be measured 2-3 times per week. During the VLCD study periods, fasting β-hydroxybutyrate levels will be measured daily in the morning using a blood ketone meter; insulin doses will be collected using insulin pump downloads and continuous glucose monitoring (CGM) profiles will be used to assess glycemic excursions on each diet, as well as the time in hypo-, eu- and hyperglycemic ranges. The purpose of this study is to examine changes in sensor glucose levels, basal and bolus insulin doses, and metabolic factors following implementation of a very low carbohydrate diet (VLCD). Sensor-derived time glucose ranges will serve as a surrogate marker of hemoglobin A1c given the short duration of the study. Safety measures of the diet will also be assessed, including daily fasting ketone levels. The first hypothesis of the study is that use of a VLCD with strict monitoring of ketosis will reduce glycemic variability and increase time in target range, defined as 70-180 mg/dL by reducing the time in the hyperglycemic (>180 mg/dL) and hypoglycemic ranges (<70 mg/dL). Decreased carbohydrate intake will lead to less postprandial hyperglycemia. Lower insulin doses for meals and snacks as a result of decreased carbohydrate intake will lessen postprandial hypoglycemia as well.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: February 20, 2022
• Est. primary completion date: February 20, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 13 Years to 25 Years

Eligibility

Inclusion Criteria:

• BMI 19-30 m2 for individuals at least 18 years old or BMI < 95 percentile for individuals less than 18 years old
• Participants 18 years of age must be able to read and provide written consent
• Participants under 18 years of age must be able to read and provide written assent
• Participants are managed using an insulin pump or injections
• Participant has or is willing to wear a CGM for the duration of the study
• Participant is willing to complete diet logging procedures stated above

Exclusion Criteria:

• A1c < 6.5% or > 10%
• Recent history of more than 1 of diabetic ketoacidosis (DKA) in the past 6 months
• Treatment with glucose-lowering drugs other than insulin
• Unstable psychiatric disorders, including eating disorders (DSM-V criteria)
• Weight loss medications within the last 6 months
• Females who are pregnant, lactating or planning to become pregnant in the next 6 months
• Another medical condition that precludes participation in the study

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 1
• Type 1 Diabetes

Intervention

Behavioral:
• Very Low Carbohydrate Diet
A very low carbohydrate diet (VLCD), is defined as limiting carbohydrate intake to 11% of total daily caloric intake.

Locations

Country	Name	City	State
United States	Yale-New Haven Hospital	New Haven	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
Yale University	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of Time in Target Range of 70-180 mg/dL.	The target range is 70 mg/dL - 180 mg/dL based on sensor-derived glucose levels. The outcome is reflected as the percentage of time spent in this range during the time frame.	2 weeks per intervention, up to 7 weeks
Secondary	Percentage of Time Spent > 180 mg/dL to 250 mg/dl	The percent of time spent > 180 mg/dL to 250 mg/dl based on sensor-derived glucose values. Reflected is the percentage of time spent in the range of 181-250 mg/dL.	2 weeks per intervention, up to 7 weeks
Secondary	Percent Time Spent > 250 mg/dL Based on Sensor-derived Glucose Values	The percent of time spent > 250 mg/dL based on sensor-derived glucose values. Presented is the percentage of time people spent in the range.	2 weeks per intervention, up to 7 weeks
Secondary	Percent of Time Spent > = 55 to < 70 mg/dL Based on Sensor-derived Glucose Values	The percent of time spent > = 55 to < 70 mg/dL based on sensor-derived glucose values. Reflected is the percentage of time within range.	2 weeks per intervention, up to 7 weeks
Secondary	Percent Time Spent < 55 mg/dL Based on Sensor-derived Glucose Values	The percent of time spent < 55 mg/dL based on sensor-derived glucose values during the timeframe. Presented is the percentage of overall time spent in the specified range.	2 weeks per intervention, up to 7 weeks
Secondary	Total Daily Insulin Dose	The total daily insulin dose will be defined as the average total daily insulin dose will be calculated over 2 weeks. Values represent the mean units/kg/day for the 2 week period.	2 weeks per intervention, up to 7 weeks
Secondary	Average Sensor Glucose Level	The average sensor glucose level recorded by the continuous glucose monitor over the 2 week dietary period in mg/dL.	2 weeks per intervention, up to 7 weeks